Archive for June, 2011
« Previous EntriesA Role For Glia In The Progression Of Rett Syndrome – RedOrbit
Thursday, June 30th, 2011
A Role For Glia In The Progression Of Rett SyndromeRedOrbitThe idea that neurons and glia might serve different roles in Rett Syndrome, in initiation and progression of symptoms, is reminiscent of the situation in another neurological disorder, an inherited form of ALS. Thus, a role for glia may turn out to be …and more »
It’s Tick Season Again, Don’t Get Bitten – PR Web (press release)
Thursday, June 30th, 2011It's Tick Season Again, Don't Get BittenPR Web (press release)The symptoms of Lyme disease (also known as the Great Imitator) may mimic those of multiple sclerosis, lupus, chronic fatigue, fibromyalgia, mononucleosis, Alzheimers, Guillian-Barre Syndrome, ALS, rheumatoid arthritis, Parkinson's Disease, …and more »
Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell … – WorldPressOnline (press release)
Thursday, June 30th, 2011Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell …WorldPressOnline (press release)… right away if you experience any such symptoms; further injection of BOTOX ® or BOTOX ® Cosmetic should be discontinued. Tell your doctor about all your muscle or nerve conditions such as amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), …and more »
Ottawa to fund MS trials – Calgary Herald
Thursday, June 30th, 2011Ottawa to fund MS trialsCalgary Herald… of veins in the neck which drain blood from the brain, results in a medical condition known as CCSVI, or chronic cerebrospinal Venus insufficiency, which may cause MS symptoms. CCSVI has also been recently linked to Parkinson's disease and ALS. …and more »
Ottawa announces MS clinical trials – Regina Leader-Post
Thursday, June 30th, 2011Ottawa announces MS clinical trialsRegina Leader-Post… of veins in the neck which drain blood from the brain, results in the medical condition known as CCSVI, or chronic cerebrospinal venus insufficiency, which may cause MS symptoms. CCSVI has also been recently linked to Parkinson's disease and ALS. …and more »
A role for glia in the progression of Rett syndrome – Science Daily (press release)
Thursday, June 30th, 2011A role for glia in the progression of Rett syndromeScience Daily (press release)The idea that neurons and glia might serve different roles in Rett Syndrome, in initiation and progression of symptoms, is reminiscent of the situation in another neurological disorder, an inherited form of ALS. Thus, a role for glia may turn out to be [...]
Ottawa announces MS clinical trials – Vancouver Sun
Wednesday, June 29th, 2011Ottawa announces MS clinical trialsVancouver Sun… of veins in the neck which drain blood from the brain, results in a medical condition known as CCSVI, or chronic cerebrospinal venus insufficiency, which may cause MS symptoms. CCSVI has also been recently linked to Parkinson's disease and ALS. …and more »
Ottawa announces MS clinical trials – Montreal Gazette
Wednesday, June 29th, 2011Ottawa announces MS clinical trialsMontreal Gazette… of veins in the neck which drain blood from the brain, results in a medical condition known as CCSVI, or chronic cerebrospinal venus insufficiency, which may cause MS symptoms. CCSVI has also been recently linked to Parkinson's disease and ALS. …and more »
10 Things You Should Know About Lyme and Other Tick-Borne Diseases – HealthNewsDigest.com
Wednesday, June 29th, 2011HealthNewsDigest.com 10 Things You Should Know About Lyme and Other Tick-Borne DiseasesHealthNewsDigest.comThe symptoms of Lyme disease (also known as the Great Imitator) may mimic those of multiple sclerosis, lupus, chronic fatigue, fibromyalgia, mononucleosis, Alzheimers, Guillian-Barre Syndrome, ALS, rheumatoid arthritis, Parkinson's Disease, …and more »
AMORFIX ANNOUNCES FISCAL 2011 YEAR END RESULTS – DigitalJournal.com (press release)
Wednesday, June 29th, 2011AMORFIX ANNOUNCES FISCAL 2011 YEAR END RESULTSDigitalJournal.com (press release)Amorfix's successful patenting of the SOD1 targets have particular importance for treatment of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, a key Amorfix program. Dr. Neil Cashman, the Chief Scientific Officer of Amorfix, has identified …and more »
« Previous Entries